Skip to main content
. 2016 Nov 16;6:37184. doi: 10.1038/srep37184

Figure 5. Inhibition of Cx43 and ERK signaling decreases osteogenic marker gene expression in vivo.

Figure 5

(A) Tenotomy mice were treated by local injection of Cx43 shRNA or intraperitoneal injection of U0126. HO tissues were decalcified, and expression of Cx43, p-ERK, ERK, Runx2 and BSP was detected by immunohistochemistry at week 8. (B) Cx43, p-ERK, Runx2 and BSP expression in the HO tissues was quantified.